Abnormal activation of the SHH pathway can lead to the genesis of an aggressive form of basal cell carcinoma called ‘Gorlin’s syndrome.’ The SHH pathway is also abnormally activated in medulloblastoma and breast cancer [21,22]. The gene discussed is SHH; the disease is breast cancer.